Navigation Links
Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest
Date:4/14/2008

- Faster delivery, efficient supply chain, and reduced cost for

pharmaceutical manufacturers

NEW YORK, April 14 /PRNewswire/ -- Sumitomo Corporation of America (SCOA) has reached an agreement with Chiral Quest, Inc., a manufacturer and developer of chiral products using proprietary chiral technologies, for the distribution and sale of chiral products to the pharmaceutical industry.

Effective immediately, Sumitomo will be the exclusive sales agent for Chiral Quest in Japan and selected worldwide accounts.

More than 40 percent of the ethical drugs manufactured today utilize chiral intermediate technology. Chiral chemocatalysts play a key role in the manufacture of medicines, fine chemicals, agricultural chemicals, and flavors and fragrances.

"Chiral Quest is now in an expansion phase, and Sumitomo's international network of marketing and distribution facilities will enable us to provide our specialty chiral molecules quickly to pharmaceutical manufacturers globally at competitive prices," said Dr. Joseph Marasco, CEO of Chiral Quest. "This is a venture that will be welcomed by the chiral molecule marketplace, and will allow us to efficiently serve our growing client base."

Chiral Quest has wholly owned patents on a range of innovative chemical catalysts and processes used in the synthesis of chiral molecules. The company's primary laboratory and manufacturing facilities in New Jersey and China will now be supported by Sumitomo's extensive marketing capability and distribution network. Additional information on Chiral Quest is available at their website http://www.chiralquest.com/.

"Sumitomo has been a major supplier to the global pharmaceutical industry for over the past four decades," noted Yasunori Ishibashi, senior director of the SCOA Medical Sciences Group. "This collaboration makes it possible for Sumitomo to play a significant rol
'/>"/>

SOURCE Sumitomo Corporation of America
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
2. IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
3. Sigma-Aldrich Corporation 1st Quarter 2008 Earnings Conference Call
4. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
5. Chem Rx Corporation Reports Full Year 2007 Financial Results
6. Chem Rx Corporation Postpones Conference Call to Review Full Year 2007 Financial Results
7. Genaera Corporation Announces 2007 Financial Results
8. Chem Rx Corporation Schedules Conference Call to Review Full Year 2007 Financial Results
9. Immunosyn Corporation Announces 2007 Results, Files 10KSB
10. Spectros Corporation Reports 2007 Year-Over-Year Sales Rise 36%
11. Lentigen Corporation Announces Exclusive Licensing Agreement With Case Western Reserve University to Develop Novel Stem-Cell Therapy for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Vivakor, Inc. (OTC Bulle...ders of record on December 1, 2009 will receive th...ica, Inc. that was previously approved by Vivakor,...Nevada corporation of which Vivakor owned approxim...record date. The distribution date is still expect...
(Date:12/4/2009)...wire/ -- Stemline Therapeutics, Inc. today announc...R targeting agents, SL-401 and SL-501, in both in... leukemia (CML) have been selected for poster pres...e American Society of Hematology (ASH), to be held...r will be presented by Stemline,s collaborators at...
(Date:12/3/2009)...swire/ -- JourneyLite of Houston, LLC announced ...tients a second surgical option, vertical sleeve ...m that it currently performs. The first sleeve ga...by surgeon partner, Matthew St. Laurent, MD on O...well. ,, The Vertical Sleeve Gastrectomy (also ...
(Date:12/3/2009)...swire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.... update on its European commercial launch of MuGar... debilitating side effect of radiation treatment a...y Access, partner, SpePharm, in six European count...eece and Sweden. Access is conducting pre-marketin...
Breaking Biology Technology:Vivakor Confirms Record Date of Stock Dividend 2Vivakor Confirms Record Date of Stock Dividend 3Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH) 2JourneyLite of Houston Now Offering Sleeve Gastrectomy 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch in Europe 4
... Claire, Wis. - StrandVision LLC , an online dig...ital signage hardware supplier in Silverdale, Wash...joint marketing agreement. , ,Under the agreement,...ided with a custom login to the Pacific Signage on...hat will help them specify, design and implement d...
...ison, Wis. - If wireless keeps growing at its pre... get their work done, says a wireless channel mana...xander, spoke at a recent Accelerate Madison pro...unications could be a defining feature for corpora...and enhancements increasing, mobility has become t...
...ison, Wis. -- A proposed ban on all human embryon...ate Senate Tuesday, a proposal opposed by many in ...n, known as AB 499, would outlaw not only cloning ... call therapeutic or research cloning, in which an...al subject for the purposes of harvesting stem cel...
Other Biology Technology:Cisco manager touts wireless advantages 2Cloning ban comes before Wisconsin Senate on Tuesday 2Cloning ban comes before Wisconsin Senate on Tuesday 3
(Date:12/2/2009)..., PHILADELPHIA People who smoke their first cigar...er levels of cotinine, a by-product of nicotine wh...moke, regardless of the number of cigarettes smoke... the risk of lung cancer, our results suggest that... especially at risk for lung cancer," said researc...
(Date:12/2/2009)...ILADELPHIA Assurance of a cancer-free status did ...puterized tomography (CT) lung-cancer screening pr...rs wrote in a study published in Cancer Epidemiol...erican Association for Cancer Research. The Decemb...These findings should negate widespread concern in...
(Date:12/2/2009)...Researchers from the University of Georgia College...dual discovery that could open new avenues for tre...vastating single-celled protozoan parasite that co...f whole-genome sequencing, researchers found that ... bacteria: Bacteroides, which are usually found f...
Breaking Biology News(10 mins):Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 2UGA researchers lead team in discovery involving devastating freshwater fish parasite, 'Ich' 3Swine Flu Continues to Wane 62639 1Swine Flu Continues to Wane 62639 2High Risk Women May Often Avoid Using Tamoxifen 62636 1High Risk Women May Often Avoid Using Tamoxifen 62636 2Live Webinar 3A Pandemic + Recession 3D Webcasting 3A Cost Effective Streaming for Public Health Communications 62633 1Live Webinar 3A Pandemic + Recession 3D Webcasting 3A Cost Effective Streaming for Public Health Communications 62633 2Live Webinar 3A Pandemic + Recession 3D Webcasting 3A Cost Effective Streaming for Public Health Communications 62633 3
...ble canaries in the coal mine, well-recognized for...through their presence and abundance in forest lan...bioindicators that the USDA Forest Services Forest...nitors populations of the symbiotic organisms as p...s. , A new report published by the Pacific Nort...
...OR, N.Y. Max Perutz, a pioneer in the field of p...ne of the first to study the molecular structures ...Georgina Ferry, was recently published by Cold Spr... just a scientist, wrote Dr. Richard E. Dickerson ...rotein Science . [H]e was a fine human being with...
...raordinary action of a new cellular therapy came t...ing in a recent study reported in the April issue ... Germany were able to observe the repair action of...od-derived cells capable of developing into adult ... heart tissue and corrected blood flow imbalance w...
Other Biology News:Power of molecular imaging reveals secrets of the heart 2
Rabbit Anti-Human SNAPAP Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Mouse Anti-Human OSCAR Monoclonal Antibody, Unconjugated, Clone 259501 from R&D Systems
Goat Anti-Mouse IGSF4 Polyclonal Antibody, Unconjugated from R&D Systems
Rat Anti-Mouse Activin RIB / ALK-4 Monoclonal Antibody, Unconjugated, Clone 207304 from R&D Systems
Biology Products: